Cites del registre
Cita APA (7th ed.)
Kryeziu, K., Moosavi, S. H., Bergsland, C. H., Guren, M. G., Eide, P. W., Totland, M. Z., . . . Lothe, R. A. (2021). Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases. BMC.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Kryeziu, Kushtrim, et al. Increased Sensitivity to SMAC Mimetic LCL161 Identified by Longitudinal Ex Vivo Pharmacogenomics of Recurrent, KRAS Mutated Rectal Cancer Liver Metastases. BMC, 2021.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Kryeziu, Kushtrim, et al. Increased Sensitivity to SMAC Mimetic LCL161 Identified by Longitudinal Ex Vivo Pharmacogenomics of Recurrent, KRAS Mutated Rectal Cancer Liver Metastases. BMC, 2021.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.